How do you interpret and manage low Insulin-like Growth Factor 1 (IGF1) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation and Management of Low IGF-1 Levels

Low IGF-1 levels require a systematic evaluation of underlying causes before initiating treatment, with priority given to addressing nutritional status and energy availability as first-line interventions. 1

Causes of Low IGF-1

Low IGF-1 levels can result from various conditions:

  • Primary causes:

    • Growth hormone deficiency
    • Growth hormone resistance
    • Genetic disorders affecting IGF-1 production 2
    • ALS (acid-labile subunit) deficiency 2
  • Secondary causes:

    • Malnutrition or low energy availability 1, 3
    • Severe hypothyroidism 1
    • Oral estrogen therapy 1
    • Liver disease 4
    • Uncontrolled diabetes 4
    • Inflammatory conditions

Diagnostic Approach

  1. Verify low IGF-1 using age-specific and sex-specific reference ranges 1

    • IGF-1 levels naturally decline with age
    • Compare to appropriate normative data
  2. Rule out non-GH deficiency causes:

    • Assess nutritional status and energy availability 3, 5
    • Check thyroid function (TSH, free T4) 3, 1
    • Evaluate liver and kidney function 1
    • Review medications (especially oral estrogens) 1
  3. Evaluate for GH deficiency:

    • GH stimulation testing (insulin tolerance test or GHRH-arginine test) 1
    • Pituitary MRI to evaluate for structural abnormalities 1
    • Complete pituitary hormone assessment (TSH, ACTH, FSH, LH, prolactin) 1

Management Algorithm

Step 1: Address Underlying Causes

  • If nutritional deficiency/low energy availability:

    • Increase caloric intake by 20-30% over baseline energy needs 3
    • Target energy availability ≥45 kcal/kg of fat-free mass 3
    • Consider nutritional consultation 3
    • Monitor weight with goal of 0.5 kg gain every 7-10 days if underweight 3
  • If hypothyroidism:

    • Initiate thyroid hormone replacement 3
  • If pituitary adenoma or other structural abnormality:

    • Refer to neurosurgery for evaluation 1
    • Consider medical therapy based on adenoma type 3

Step 2: Monitor Response

  • Recheck IGF-1 levels after addressing underlying causes
  • For nutritional interventions, improvement in IGF-1 can be seen within days to weeks 3, 5
  • IGF-1 is more sensitive to nutritional changes than albumin or transferrin 5

Step 3: Consider GH Replacement Therapy

  • If confirmed GH deficiency and no improvement with addressing underlying causes:
    • Initiate GH replacement therapy 1
    • Titrate dose based on IGF-1 levels 1
    • Monitor for side effects (fluid retention, joint pain, carpal tunnel syndrome)

Special Considerations

  • Female athletes with low energy availability:

    • Low IGF-1 is part of the Female Athlete Triad 3
    • Recovery of energy status precedes recovery of menstrual status and bone mineral density 3
    • Increasing energy availability is the primary intervention 3
  • Acromegaly/GH excess:

    • Paradoxically, some patients with acromegaly may have low IGF-1 due to GH receptor antagonism 3
    • Requires different management approach with somatostatin analogues, dopamine agonists, or pegvisomant 3
  • Genetic causes:

    • Patients with genetic defects in IGF-1 production may have more modest growth failure than expected 2
    • May require lifelong IGF-1 replacement

Monitoring and Follow-up

  • Regular IGF-1 measurements to assess treatment efficacy
  • Bone density assessment due to increased osteoporosis risk 1
  • Regular follow-up imaging if structural pituitary abnormality is identified 1
  • Monitor for development of other pituitary hormone deficiencies 1

Remember that IGF-1 is a sensitive marker of nutritional status, and nutritional interventions should be the first-line approach before considering hormone replacement therapy in most cases of low IGF-1.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.